Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
STAA

STAA - STAAR Surgical Co Stock Price, Fair Value and News

$19.17+0.13 (+0.68%)
Market Closed

30/100

STAA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

30/100

STAA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$15.31

Target 3M

$18.07

Target 6M

$17.05

STAA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

STAA Price Action

Last 7 days

-7.0%

Last 30 days

-18.0%

Last 90 days

-27.7%

Trailing 12 Months

-23.3%

STAA RSI Chart

STAA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

STAA Valuation

Market Cap

953.6M

Price/Earnings (Trailing)

-9.9

Price/Sales (Trailing)

4.14

EV/EBITDA

-9.34

Price/Free Cashflow

-24.11

STAA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$15.31

Target 3M

$18.07

Target 6M

$17.05

STAA Fundamentals

STAA Revenue

Revenue (TTM)

230.6M

Rev. Growth (Yr)

6.93%

Rev. Growth (Qtr)

113.75%

STAA Earnings

Earnings (TTM)

-96.4M

Earnings Growth (Yr)

-10.98%

Earnings Growth (Qtr)

152.84%

STAA Profitability

EBT Margin

-39.87%

Return on Equity

-27.24%

Return on Assets

-21.12%

Free Cashflow Yield

-4.15%

STAA Investor Care

Shares Dilution (1Y)

0.95%

Diluted EPS (TTM)

-1.95

STAA Alerts

  • 1 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025279.1M224.4M230.6M0
2024326.2M332.9M341.2M313.9M
2023294.7M305.9M310.2M322.4M
2022242.9M261.7M279.3M284.4M
2021179.0M206.2M217.5M230.5M
2020152.8M148.3M156.3M163.5M
2019129.4M135.2M142.5M150.2M
201897.4M109.3M117.6M124.0M
201783.5M84.5M87.9M90.6M
201677.5M79.9M81.2M82.4M
201573.7M72.3M72.8M77.1M
201474.4M76.3M77.4M75.0M
201366.3M68.5M69.7M72.2M
201263.4M63.1M63.7M63.8M
201156.0M58.7M60.8M62.8M
201000055.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About STAAR Surgical Co

STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
 CEO
 WEBSITEstaar.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES882

STAAR Surgical Co Frequently Asked Questions

STAA is the stock ticker symbol of STAAR Surgical Co. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of STAAR Surgical Co is 953.55 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check STAA's fair value in chart for subscribers.

The fair value guage provides a quick view whether STAA is over valued or under valued. Whether STAAR Surgical Co is cheap or expensive depends on the assumptions which impact STAAR Surgical Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STAA.

As of Wed Jan 28 2026, STAA's PE ratio (Price to Earnings) is -9.9 and Price to Sales (PS) ratio is 4.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STAA PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, STAAR Surgical Co has provided 0.114 (multiply by 100 for percentage) rate of return.